Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Gpx Medical Ab |
| Country | Sweden |
| Start Date | May 02, 2022 |
| End Date | Nov 30, 2022 |
| Duration | 212 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2022-00895_Vinnova |
Purpose and goal: ** Denna text är maskinöversatt ** The purpose of the project was to carry out a price analysis to get an understanding of how potential price levels for NEOLA® affected the market´s willingness to purchase the product.
The price analysis has given the Company exactly the understanding it sought. Today, the Company knows what price levels the American market can tolerate and the expected impact NEOLA® can have on the American market. Expected results and effects:
The project gives GPX Medical a much stronger foundation to be able to achieve international success in the United States by laying the foundation for commercialization in the American market. In addition, the company´s competitiveness is strengthened as the right knowledge of the willingness to pay for different price models means that the company can set the right price level for NEOLA®.
Approach and implementation: The project is closely linked to our commercialization strategy for the US market and the work included: - Cost analysis of NEOLA® - Development of various potential price models and price levels for evaluation - Implementation and analysis of a potential market research buyer
- Development of final initial sales price and payment model for NEOLA® - Implementation of project insights in the market strategy for the US market
Gpx Medical Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant